JAZZ
Jazz Pharmaceuticals plc
Latest Form 4:Sale$19.2MbyIannone Robert (EVP, Global Head of R&D & CMO) · filed Aug 31, 2026
Jazz Pharmaceuticals plc (JAZZ) has 71 SEC Form 4 filings (127 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Aug 31, 2026.
The most active filer is Director COZADD BRUCE C with 11 filings. Insiders have net sold $29.8M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Renee D. Gala
- Employees:2,890
- HQ:Dublin, IE
- IPO:2007-06-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$67.2M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Market Cap
$15.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Iannone RobertFirst in 10 months | EVP, Global Head of R&D & CMO | Sale | 76,921 | $19.2M | Aug 31 | SEC ↗ |
| Director | Sale | 6,000 | $1.5M | Aug 5 | SEC ↗ | |
| Director | Sale | 6,000 | $1.4M | Jul 6 | SEC ↗ | |
Smith Mark DouglasFirst filing | Director | Sale | 1,157 | $267K | Jun 17 | SEC ↗ |
| EVP & Chief Legal Officer | Sale | 1,200 | $278K | Jun 12 | SEC ↗ | |
| Director | Sale | 6,000 | $1.4M | Jun 3 | SEC ↗ | |
Pearce SamanthaFirst filing | EVP, Chief Commercial Officer | Sale | 6,907 | $1.6M | Jun 1 | SEC ↗ |
Patil Neena MFirst in 3 months | EVP & Chief Legal Officer | Sale | 1,192 | $282K | Jun 1 | SEC ↗ |
Winningham Rick EFirst in 6 months | Director | Sale | 2,741 | $662K | May 27 | SEC ↗ |
McSharry Heather AnnFirst in 6 months | Director | Sale | 2,000 | $482K | May 27 | SEC ↗ |
| Director | Sale | 6,000 | $1.2M | May 5 | SEC ↗ | |
| Director | Sale | 6,000 | $1.1M | Apr 3 | SEC ↗ | |
| SVP, Chief Accounting Officer | Sale | 1,287 | $235K | Mar 9 | SEC ↗ | |
COZADD BRUCE CFirst in 3 months | Director | Sale | 6,000 | $1.1M | Mar 4 | SEC ↗ |
Patil Neena MFirst filing | EVP & Chief Legal Officer | Sale | 55,600 | $10.7M | Mar 2 | SEC ↗ |
RIEDEL NORBERT GFirst filing | Director | Sale | 3,415 | $656K | Mar 2 | SEC ↗ |
| SVP, Chief Accounting Officer | Sale | 1,253 | $243K | Mar 2 | SEC ↗ | |
| SVP, Chief Accounting Officer | Sale | 1,117 | $213K | Mar 2 | SEC ↗ | |
| SVP, Technical Operations | Sale | 5,343 | $1.0M | Mar 2 | SEC ↗ | |
Henderson Mary ElizabethFirst filing | SVP, Technical Operations | Sale | 2,238 | $379K | Dec 11 | SEC ↗ |
| SVP, Chief Accounting Officer | Sale | 4,660 | $798K | Dec 9 | SEC ↗ | |
| Director | Sale | 77,500 | $13.8M | Dec 1 | SEC ↗ | |
McSharry Heather AnnFirst filing | Director | Sale | 3,415 | $607K | Nov 24 | SEC ↗ |
Carr PatriciaFirst filing | SVP, Chief Accounting Officer | Sale | 5,319 | $968K | Nov 20 | SEC ↗ |
| Director | Sale | 18,000 | $3.3M | Nov 20 | SEC ↗ | |
Winningham Rick EFirst filing | Director | Sale | 5,500 | $995K | Nov 20 | SEC ↗ |
Iannone RobertFirst filing | EVP, Global Head of R&D & CMO | Sale | 7,159 | $1.2M | Nov 19 | SEC ↗ |
| Director | Sale | 2,000 | $264K | Oct 3 | SEC ↗ | |
| Director | Sale | 3,500 | $490K | Oct 3 | SEC ↗ | |
COZADD BRUCE CFirst filing | Director | Sale | 6,000 | $772K | Sep 4 | SEC ↗ |
Related companies
Jazz Pharmaceuticals plc is in the Healthcare sector.